Frankfurt - Delayed Quote EUR
HBM Holdings Limited (6XY.F)
1.0000
+0.0200
+(2.04%)
As of 9:59:02 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
30,676
30,676
-19,122
-99,964
-125,609
Investing Cash Flow
6,555
6,555
28,087
137,590
-76,903
Financing Cash Flow
-10,237
-10,237
-29,143
70,575
1,589
End Cash Position
166,821
166,821
140,324
161,705
56,304
Capital Expenditure
-235
-235
-2,480
-18,438
-14,202
Issuance of Capital Stock
--
--
-354
-753
-8,115
Issuance of Debt
33,162
33,162
11,426
77,491
12,040
Repayment of Debt
-38,123
-38,123
-35,211
-1,352
0
Repurchase of Capital Stock
-644
-644
-354
--
--
Free Cash Flow
30,441
30,441
-21,602
-118,402
-139,811
12/31/2021 - 2/3/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALNEV.PA Neovacs S.A.
0.0066
0.00%
NBTX Nanobiotix S.A.
3.8750
+3.89%
ALLK Allakos Inc.
0.3291
-0.06%
OVID Ovid Therapeutics Inc.
0.2949
+3.11%
PRQR ProQR Therapeutics N.V.
1.5500
+1.31%
ACIU AC Immune SA
1.5300
-2.55%
BTAI BioXcel Therapeutics, Inc.
1.3700
-4.20%
TPST Tempest Therapeutics, Inc.
6.55
-3.53%
FGEN FibroGen, Inc.
0.2999
+0.20%
ADAP Adaptimmune Therapeutics plc
0.2720
+8.80%